BSX Q3 2018 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q3 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.4B+7.7% YoY

Gross Profit

$1.6B66.2% margin

Operating Income

$411M17.2% margin

Net Income

$432M18.1% margin

EPS (Diluted)

$0.31

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

$501M

Free Cash Flow

$389M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$20.4B

Total Liabilities

$12.1B

Stockholders' Equity

$8.3B

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.4B	$2.2B	+7.7%
Gross Profit	$1.6B	$1.4B	+9.8%
Operating Income	$411M	$376M	+9.3%
Net Income	$432M	$283M	+52.7%

Revenue Segments

Cardiovascular

$908M55%

MedSurg

$746M45%

Geographic Segments

UNITED STATES

$1.4B57%

Non-US

$1.0B43%